Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertram Pitt

Showing results (241-250 of 687) with videos related to

Pageof 69
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)|November 7, 2006
Angiotensin receptor blockade improves vascular compliance in healthy normotensive elderly individuals: results from a randomized double-blind placebo-controlled trialSanjay Rajagopalan, Mbabazi Kariisa, Santo Dellegrottaglie, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 6, 2010
Serum potassium and outcomes in CKD: insights from the RRI-CKD cohort studySonal Korgaonkar, Anca Tilea, Brenda W Gillespie, et al.
European Journal of Heart Failure|March 27, 2018
Factors associated with underuse of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: an analysis of 11 215 patients from the Swedish Heart Failure RegistryGianluigi Savarese, Juan-Jesus Carrero, Bertram Pitt, et al.
American Heart Journal|March 3, 2015
A reappraisal of loop diuretic choice in heart failure patientsJonathan Buggey, Robert J Mentz, Bertram Pitt, et al.
International Journal of Cardiology|March 7, 2021
Serum microRNAs and antifibrotic response to eplerenone in acute myocardial infarction complicated by systolic dysfunctionSusan Stienen, João Pedro Ferreira, Christian Bär, et al.
Circulation|April 29, 2009
Extracellular cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) studyWafae Iraqi, Patrick Rossignol, Michael Angioi, et al.
Journal of the American College of Cardiology|October 1, 2016
Hyperkalemia in Heart FailureChaudhry M S Sarwar, Lampros Papadimitriou, Bertram Pitt, et al.
European Journal of Heart Failure|March 12, 2011
Impact of diabetes mellitus on outcomes in patients with acute myocardial infarction and systolic heart failurePrakash C Deedwania, Mustafa I Ahmed, Margaret A Feller, et al.
Pacing and Clinical Electrophysiology : PACE|April 12, 2003
QT dispersion has no prognostic value in patients with symptomatic heart failure: an ELITE II substudyYi Gang, Takuya Ono, Katerina Hnatkova, et al.
Archives of Cardiovascular Diseases|March 18, 2014
Heart failure with systolic dysfunction complicating acute myocardial infarction - differential outcomes but similar eplerenone efficacy by ST-segment or non-ST-segment elevation: A post hoc substudy of the EPHESUS trialSylvain Carillo, Yan Zhang, Renaud Fay, et al.
Pageof 69

Showing results (241-250 of 687) with videos related to

Sort By:
Pageof 69
Journal of Clinical Hypertension (Greenwich, Conn.)|November 7, 2006
Angiotensin receptor blockade improves vascular compliance in healthy normotensive elderly individuals: results from a randomized double-blind placebo-controlled trialSanjay Rajagopalan, Mbabazi Kariisa, Santo Dellegrottaglie, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 6, 2010
Serum potassium and outcomes in CKD: insights from the RRI-CKD cohort studySonal Korgaonkar, Anca Tilea, Brenda W Gillespie, et al.
European Journal of Heart Failure|March 27, 2018
Factors associated with underuse of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: an analysis of 11 215 patients from the Swedish Heart Failure RegistryGianluigi Savarese, Juan-Jesus Carrero, Bertram Pitt, et al.
American Heart Journal|March 3, 2015
A reappraisal of loop diuretic choice in heart failure patientsJonathan Buggey, Robert J Mentz, Bertram Pitt, et al.
International Journal of Cardiology|March 7, 2021
Serum microRNAs and antifibrotic response to eplerenone in acute myocardial infarction complicated by systolic dysfunctionSusan Stienen, João Pedro Ferreira, Christian Bär, et al.
Circulation|April 29, 2009
Extracellular cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) studyWafae Iraqi, Patrick Rossignol, Michael Angioi, et al.
Journal of the American College of Cardiology|October 1, 2016
Hyperkalemia in Heart FailureChaudhry M S Sarwar, Lampros Papadimitriou, Bertram Pitt, et al.
European Journal of Heart Failure|March 12, 2011
Impact of diabetes mellitus on outcomes in patients with acute myocardial infarction and systolic heart failurePrakash C Deedwania, Mustafa I Ahmed, Margaret A Feller, et al.
Pacing and Clinical Electrophysiology : PACE|April 12, 2003
QT dispersion has no prognostic value in patients with symptomatic heart failure: an ELITE II substudyYi Gang, Takuya Ono, Katerina Hnatkova, et al.
Archives of Cardiovascular Diseases|March 18, 2014
Heart failure with systolic dysfunction complicating acute myocardial infarction - differential outcomes but similar eplerenone efficacy by ST-segment or non-ST-segment elevation: A post hoc substudy of the EPHESUS trialSylvain Carillo, Yan Zhang, Renaud Fay, et al.
Pageof 69